Structure via PubChem · Public domain (PubChem)
ibopamine
Sign in to saveIbopamine is a sympathomimetic drug, designed as a prodrug of epinine (deoxyepinephrine or N-methyldopamine), used in ophthalmology. It induces mydriasis. It also has been investigated for use in the treatment of congestive heart failure.
In the Vinony graph
Vinony's link graph records 2,099 inbound references to ibopamine, and connects out to adrenergic receptor, propranolol and sympathomimetic drug.
It sits within the topics Alpha1-adrenergic agonists, Alpha2-adrenergic agonists and Beta-adrenergic agonists.
Vinony links it to 6 Wikipedia language editions.
Chemical data
- Formula
- C17H25NO4
- Molecular weight
- 307.4 g/mol
- IUPAC name
- [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- cardiovascular disease
via ChEMBL · EBI
Research
359 papers- Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.Drugs & aging · 1993
- Clinical pharmacology of ibopamine.The American journal of medicine · 1991
- Neurohormonal and hemodynamic effects of ibopamine.Clinical cardiology · 1995
- Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.Drugs · 1988
- [Ibopamine--clinical results].Zeitschrift fur Kardiologie · 1991
via PubMed
Wikidata facts
- Mass
- 307.178
Show 3 more facts
- chemical formula
- C₁₇H₂₅NO₄
- canonical SMILES
- CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C
- found in taxon
- Melodinus fusiformis
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
6 sectionsContents
- Pharmacokinetics
- Pharmacodynamics
- Toxicology
- Clinical Use
- See also
- References
Ibopamine is a sympathomimetic drug, designed as a prodrug of epinine (deoxyepinephrine or N-methyldopamine), used in ophthalmology. It induces mydriasis. It also has been investigated for use in the treatment of congestive heart failure.
It acts on D1 and α-adrenergic receptors as an agonist.
Excerpted from Wikipedia’s “ibopamine” article, available under the CC BY-SA 4.0 licence.